囊性纤维化年在审查中 2025年
Sophia T Pallenberg1, Ester Zamarrón de Lucas2, Andrea Párniczky3
1Clinic for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.
概括
囊性纤维化 (CF) 治疗正在改善肺功能,但感染和炎症仍然存在. 需要新的疗法和终身护理模式,以满足老龄化,多样化的CF人口.
科学领域:
- 肺部医学 肺部医学
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- 囊性纤维化 (CF) 管理因CFTR调节器 (CFTRm) 而不断发展.
- 尽管调节器有好处,但感染,炎症和并发症等挑战仍然存在.
- CF正在转变为一种慢性,异质的疾病,需要新的护理策略.
研究的目的:
- 审查2025年关于CF护理在调制器时代不断变化的景观的文献.
- 总结CFTR调节器和新兴治疗策略的进展.
- 检查感染,炎症和多系统并发症的持续挑战.
主要方法:
- 对2025年关于囊性纤维化的出版物的文献综述.
- 对当前和下一代CFTR调节器疗法的分析.
- 检查新兴的突变无知的治疗方法,抗炎药物和基因疗法.
主要成果:
- 埃尔克萨卡夫托尔/特萨卡夫托尔/伊瓦卡夫托尔 (ETI) 显示了持久的肺功能增长,但具有资格和访问差距.
- 新兴疗法包括ENaC阻断剂,中性粒细胞导向的抗炎药物和基因疗法.
- 虽然ETI减少了一些炎症标志物,但慢性感染和免疫缺陷仍然存在.
- 菌体疗法对多抗药性感染有希望;微生物组干预的影响有限.
- 增加的生存率突出显示了怀孕,恶性瘤和心血管疾病日益重要.
结论:
- 结核病护理正在转向对一个多样化,老龄化的人口进行终身,公平的管理.
- 下一代调制器和新疗法对于解决未满足的需求至关重要.
- 多学科,系统级的护理模式对于管理复杂的CF并发症至关重要.
更多相关视频
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
610
08:58Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
Published on: April 18, 2025
1.1K
相关概念视频
01:24Cystic Fibrosis: Management
593
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
593
01:23Cystic Fibrosis: Pathogenesis
960
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
960
01:24Chronic Obstructive Pulmonary Disease
2.8K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:29Chronic Pancreatitis II: Collaborative Care
447
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
447